# US 2001/0026804 A1 · Compressed microparticles for dry injection

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2001/0026804 A1
- Document ID: US20010026804A1
- Status: Published application
- Kind: A1
- Application number: 09/764,111
- Filed: 2001-01-19
- Published: 2001-10-04
- Earliest claimed: 2000-01-18
- Assignees: Ardana Bioscience Limited
- Inventors: Francois Boutignon
- Web page: https://patentgrep.com/patent/US20010026804A1

## CPC

- A61K 9/0024: {Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue (compositions for intravenous administration, normal injectable solutions or dispersions for, e.g. subcutaneous administration A61K9/0019; brain implants A61K9/0085; (coated) prostheses, catheters or stents A61L)}
- A61K 9/2095: {Tabletting processes}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The invention relates to a pharmaceutical implant for controllably releasing a drug in a subject and methods for manufacturing and administering the implant. The implant is made of associated microparticles of a drug dispersed in a biodegradable polymer. The microparticles are sufficiently associated so that the implant maintains a predetermined shape but are not fused together so as to form a single monolithic structure. The drug can be controllably released in a subject by administration of the pharmaceutical implant without the need of a suspending fluid.

## Claims

### Claim 1

A pharmaceutical implant for controllably releasing a drug comprising microparticles of one or more drugs dispersed in a biodegradable polymer, wherein the microparticles are sufficiently associated to maintain a predetermined shape of the implant without complete fusing of the polymer, for convenient administration to a subject and wherein the implant disintegrates into individual microparticles over time after administration.

### Claim 2 (depends on 1)

The pharmaceutical implant of claim 1 wherein the amount of the drug is between about 0.5 to 95 percent (w/w) of the microparticles.

### Claim 3 (depends on 1)

The pharmaceutical implant of claim 1 wherein the amount of the drug is between about 5 to 75 percent (w/w) of the microparticles.

### Claim 4 (depends on 1)

The pharmaceutical implant of claim 1 wherein the biodegradable polymer is selected from the group consisting of polymers of lactic acid, glycolic acid, polyethylene glycols, poly(ortho esters), poly caprolactones, and copolymers thereof.

### Claim 5 (depends on 1)

The pharmaceutical implant of claim 1 further comprising one or more additives.

### Claim 6 (depends on 5)

The pharmaceutical implant of claim 5 wherein the one or more additives are selected from the group consisting of biodegradable polymers, mannitol, dextrose, inositol, sorbitol, glucose, lactose, sucrose, sodium chloride, calcium chloride, amino acids, magnesium chloride, citric acid, acetic acid, malic acid, phosphoric acid, glucuronic acid, gluconic acid, polysorbate, sodium acetate, sodium citrate, sodium phosphate, zinc stearate, aluminum stearate, magnesium stearate, sodium carbonate, sodium bicarbonate, sodium hydroxide, polyvinylpyrrolidones, polyethylene glycols, carboxymethyl celluloses, methyl celluloses, starch, and mixtures thereof.

### Claim 7 (depends on 1)

The pharmaceutical implant of claim 1 wherein the implant has a cylindrical shape, has a diameter between about 0.5 to 5 mm, and a length of between about 0.5 to 10 cm.

### Claim 8 (depends on 7)

The pharmaceutical implant of claim 7 wherein the implant has a diameter between about 1 to 3 mm and a length of between about 1 to 5 cm.

### Claim 9

A method for controllably releasing a drug in a subject comprising administering to the subject a pharmaceutical implant comprising microparticles of one or more drugs dispersed in a biodegradable polymer, wherein the microparticles are sufficiently associated to maintain a predetermined shape of the implant without complete fusing of the polymer and wherein the implant disintegrates into individual microparticles over time after administration.

### Claim 10 (depends on 9)

The method of claim 9 wherein the implant is administered intramuscularly or subcutaneously.

### Claim 11 (depends on 10)

The method claim 10 wherein the implant is administered surgically or using an implantation device.

### Claim 12 (depends on 11)

The method of claim 11 wherein the implantation device is pre-filled with the implant.

### Claim 13

A method of preparing a pharmaceutical implant for controllably releasing a drug in a subject comprising the steps of:
placing microparticles of one or more drugs dispersed in a biodegradable polymer in a forming zone defined by a vessel having an upper end and a lower end, wherein the upper end has an opening to permit the microparticles and a fluid to be introduced into the forming zone, the lower end is covered with a seal that prevents the microparticles from exiting the forming zone but allows gases and fluids to exit the forming zone;
adding a fluid to the upper end of the forming zone in an amount sufficient to evenly coat the microparticles to increase adhesion of the microparticles;
applying a pressure to the upper end of the forming zone to compact the microparticles and sufficiently associate the microparticles so that they maintain the shape of the forming zone without complete fusing of the polymer;
removing the compacted microparticles from the forming zone in the shape of the implant; and
drying the compacted microparticles to provide a pharmaceutical implant that disintegrates into individual microparticles over time after the implant is administered to a subject.

### Claim 14 (depends on 13)

The method of claim 13 wherein the lower end of the forming zone is adapted to receive a vacuum and further comprising the step of applying a vacuum to the lower end of the forming zone, after the fluid is added, to evenly coat the microparticles with the fluid.

### Claim 15 (depends on 13)

The method of claim 13 wherein the vacuum creates a reduced pressure of between about 2 and 50 inches of mercury.

### Claim 16 (depends on 13)

The method of claim 13 further comprising combining the microparticles with one or more additives to form a mixture before placing the mixture in the forming zone.

### Claim 17 (depends on 16)

The method of claim 16 wherein the additives are selected from the group consisting of biodegradable polymers, mannitol, dextrose, inositol, sorbitol, glucose, lactose, sucrose, sodium chloride, calcium chloride, amino acids, magnesium chloride, citric acid, acetic acid, malic acid, phosphoric acid, glucuronic acid, gluconic acid, polysorbate, sodium acetate, sodium citrate, sodium phosphate, zinc stearate, aluminum stearate, magnesium stearate, sodium carbonate, sodium bicarbonate, sodium hydroxide, polyvinylpyrrolidones, polyethylene glycols, carboxymethyl celluloses, methyl celluloses, starch, and mixtures thereof.

### Claim 18 (depends on 16)

The method of claim 16 wherein the additive is present in an amount of between about 0.05 percent (w/w) and 75 percent (w/w) of the implant.

### Claim 19 (depends on 13)

The method of claim 13 wherein the fluid is added in an amount of between about 20 percent (v/w) and 200 percent (v/w) of the weight of the microparticles.

### Claim 20 (depends on 13)

The method of claim 13 wherein the fluid is one or more fluids selected from the group consisting of water, ethanol, methanol, and heptane.

### Claim 21 (depends on 13)

The method of claim 13 further comprising adding a solute to the one or more fluids.

### Claim 22 (depends on 21)

The method of claim 21 wherein the solute is selected from the group consisting of mannitol, salts, polyethylene glycol, acids, bases, and mixtures thereof.

### Claim 23 (depends on 13)

The method of claim 13 wherein the compacted microparticles are dried at a temperature of between about 15° C. to 40° C.

### Claim 24 (depends on 23)

The method of claim 23 further comprising drying the compacted microparticles under reduced pressure.

### Claim 25 (depends on 23)

The method of claim 23 further comprising drying the compacted microparticles in the presence of a desiccant.

### Claim 26 (depends on 13)

The method of claim 13 wherein the pressure is between about 1 kg/cm2 and 1,000 kg/cm2 and is applied for between about 1 second and 10 minutes.

### Claim 27 (depends on 13)

The method of claim 13 wherein the upper end of the forming zone is adapted to receive a plunger and pressure is applied using the plunger.

### Claim 28

A method of preparing a pharmaceutical implant for controllably releasing a drug in a subject comprising the steps of:
combining microparticles of one or more drugs dispersed in a biodegradable polymer with a fluid to form a wet granulate;
placing the wet granulate in a forming zone defined by a vessel having an upper end and a lower end, wherein the upper end permits the wet granulate to be introduced into the forming zone and the lower end prevents the microparticles from exiting the forming zone;
applying pressure to the upper end of the forming zone to compact the microparticles and sufficiently associate the microparticles so that they maintain the shape of the forming zone without complete fusing of the polymer;
removing the compacted microparticles from the forming zone in the shape of the implant; and drying the compacted microparticles to provide a pharmaceutical implant that disintegrates into individual microparticles over time after the implant is administered to a subject.

### Claim 29 (depends on 28)

The method of claim 28 further comprising combining the wet granulate with one or more additives before placing the wet granulate in the forming zone.

### Claim 30 (depends on 29)

The method of claim 29 wherein the additives are selected from the group consisting of biodegradable polymers, mannitol, dextrose, inositol, sorbitol, glucose, lactose, sucrose, sodium chloride, calcium chloride, amino acids, magnesium chloride, citric acid, acetic acid, malic acid, phosphoric acid, glucuronic acid, gluconic acid, polysorbate, sodium acetate, sodium citrate, sodium phosphate, zinc stearate, aluminum stearate, magnesium stearate, sodium carbonate, sodium bicarbonate, sodium hydroxide, polyvinylpyrrolidones, polyethylene glycols, carboxymethyl celluloses, methyl celluloses, starch, and mixtures thereof.

### Claim 31 (depends on 29)

The method of claim 29 wherein the additive is present in an amount of between about 0.05 percent (w/w) and 75 percent (w/w) of the implant.

### Claim 32 (depends on 28)

The method of claim 28 wherein the fluid is added in an amount of between about 20 percent (v/w) and 200 percent (v/w) of the weight of the microparticles.

### Claim 33 (depends on 28)

The method of claim 28 wherein the fluid is one or more fluids selected from the group consisting of water, ethanol, methanol, and heptane.

### Claim 34 (depends on 28)

The method of claim 28 further comprising adding a solute to the one or more fluids.

### Claim 35 (depends on 34)

The method of claim 34 wherein the solute is selected from the group consisting of mannitol, salts, polyethylene glycol, acids, bases, and mixtures thereof.

### Claim 36 (depends on 28)

The method of claim 28 wherein the pressure is between about 1 kg/cm2 and 1,000 kg/cm2 and is applied for between about 1 second and 10 minutes.

### Claim 37 (depends on 28)

The method of claim 28 wherein the compacted microparticles are dried at a temperature of between about 15° C. to 40° C.

### Claim 38 (depends on 37)

The method of claim 37 further comprising drying the compacted microparticles under reduced pressure.

### Claim 39 (depends on 37)

The method of claim 37 further comprising drying the compacted microparticles in the presence of a desiccant.

### Claim 40 (depends on 28)

The method of claim 28 wherein the upper end of the forming zone is adapted to receive a plunger and pressure is applied using a plunger.
